FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in ... News-Medical.net ... Administration (FDA) has approved ASTAGRAF XLTM (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without ... |
